FTL (Ferritin Light Chain) is the light subunit of the ferritin heteropolymer, playing a crucial role in iron storage and homeostasis in the brain. Together with FTH1 (ferritin heavy chain), FTL forms the 24-subunit ferritin nanocage that sequesters excess iron and protects [neurons](/entities/neurons) from oxidative damage. [@fthftl]
FTL is a 20 kDa subunit that co-assembles with FTH1 to form the native ferritin complex:
...
FTL Protein
Overview
FTL (Ferritin Light Chain) is the light subunit of the ferritin heteropolymer, playing a crucial role in iron storage and homeostasis in the brain. Together with FTH1 (ferritin heavy chain), FTL forms the 24-subunit ferritin nanocage that sequesters excess iron and protects [neurons](/entities/neurons) from oxidative damage. [@fthftl]
Neuronal Iron Regulation: Modulates labile iron pool in dendrites and axons
Glial Function: Supports astrocyte and oligodendrocyte iron metabolism
Myelin Synthesis: Critical for oligodendrocyte iron requirements
FTL is expressed throughout the brain, with highest levels in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and basal ganglia.
Role in Neurodegeneration
Alzheimer's Disease (AD)
CSF biomarker: Elevated FTL in cerebrospinal fluid correlates with disease progression
Amyloid interaction: Ferritin binds to [amyloid-beta](/proteins/amyloid-beta), potentially modulating plaque formation
Iron dysregulation: Altered ferritin expression in AD brain regions
Parkinson's Disease (PD)
Substantia nigra: Increased ferritin accumulation in dopaminergic neurons
Neuromelanin complex: FTL associates with neuromelanin-iron complexes
Levodopa response: Ferritin levels may influence treatment response
Neuroferritinopathy
FTL mutations: Autosomal dominant mutations cause neurodegeneration with brain iron accumulation (NBIA)
Ferritin dysfunction: Impaired iron storage leads to free radical damage
Basal ganglia pathology: Characteristic iron deposition in putamen and caudate
Other Neurodegenerative Disorders
Multiple Sclerosis: Altered ferritin in demyelinating lesions
Friedreich's Ataxia: Compensatory FTL upregulation with frataxin deficiency
Aging: Age-related iron accumulation correlates with cognitive decline
Therapeutic Targeting
Therapeutic strategies targeting ferritin and iron metabolism:
| Agent | Mechanism | Development Stage | |-------|-----------|-------------------| | Iron chelators | Reduce iron-mediated oxidative stress | Clinical trials for PD/AD | | Antioxidants | Scavenge iron-generated ROS | Preclinical | | Ferritin modulators | Alter ferritin expression/function | Research |
Key Publications
[Fitzpatrick et al., Neuroferritinopathy (1999)](https://doi.org/10.1093/brain/awp207)
[Wang et al., CSF ferritin in AD (2020)](https://doi.org/10.1016/j.jns.2020.116952)
[Berg et al., Iron in Parkinson's disease substantia nigra (2001)](https://doi.org/10.1001/archneur.58.7.1155)
[Cai et al., Ferritin light chain in neurodegeneration (2018)](https://doi.org/10.1007/s12035-018-1067-z)
[Devos et al., Targeting iron in neurodegeneration (2022)](https://doi.org/10.1093/braincomms/fcac057)
Related Pages
[FTL Gene](/genes/ftl)
[FTH1 Protein](/proteins/fth1-protein)
[Iron Metabolism in Neurodegeneration](/mechanisms/iron-metabolism-neurodegeneration)